☆ 4.6 Article

Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine dose

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Related references

Note: Only part of the references are listed.

Article Infectious Diseases

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

Marcia M. L. Kho et al.

Summary: This study aimed to compare three alternative strategies for improving the COVID-19 vaccine response in kidney transplant recipients: double vaccine dose, heterologous vaccination, and temporary discontinuation of mycophenolate mofetil or mycophenolic acid. The results showed that repeated vaccination increased SARS-CoV-2-specific antibodies in kidney transplant recipients, but higher dose, heterologous vaccine, or discontinuation of immunosuppressants did not further enhance the response.

LANCET INFECTIOUS DISEASES (2023)

Add to Collection

Article Surgery

Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients

Andrew H. Karaba et al.

Summary: Neutralizing antibody (nAb) responses are weakened in solid organ transplant recipients (SOTRs) despite being fully vaccinated. Preexposure prophylaxis (PrEP) with the antibody combination tixagevimab and cilgavimab (T+C) may enhance immune protection, but its activity and durability against Omicron sublineages BA.4/5 in fully vaccinated SOTRs have not been determined. Most fully vaccinated SOTRs receiving T+C PrEP achieved neutralization against BA.4/5, but nAb activity commonly declined after 3 months. It is crucial to evaluate the optimal dose and interval of T+C PrEP to maximize protection against emerging variants.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Add to Collection

Article Surgery

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients

Andrew H. Karaba et al.

Summary: Vaccine-induced antibody responses are weaker in solid organ transplant recipients (SOTRs), and breakthrough infections are more common. Additional vaccine doses increase antibody levels in some SOTRs, but the neutralization capacity is still significantly lower than in healthy individuals.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Letter Medicine, General & Internal

Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series

Sophie Caillard et al.

ANNALS OF INTERNAL MEDICINE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

Wilfredo F. Garcia-Beltran et al.

Summary: Recent surveillance has identified the emergence of the SARS-CoV-2 Omicron variant, which carries up to 36 mutations in the spike protein and has the potential to evade vaccine-induced immunity. This study found that individuals vaccinated with mRNA vaccines exhibited strong neutralization of the Omicron variant, while most vaccinees had weak neutralization. The study also revealed that the Omicron variant infects more efficiently than other tested variants.

CELL (2022)

Add to Collection

Article Multidisciplinary Sciences

Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron

Juan Manuel Carreno et al.

Summary: The Omicron variant of SARS-CoV-2, first identified in South Africa and Botswana in November 2021, has rapidly spread globally with high transmissibility. It has an unprecedented number of mutations in its spike gene, leading to immune escape and reduced vaccine efficacy. The neutralizing and binding activity against Omicron varies among individuals with different vaccination and infection histories.

NATURE (2022)

Add to Collection

Article Cell Biology

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients

Xavier Charmetant et al.

Summary: Transplant recipients treated with immunosuppression have a lower response to COVID-19 vaccines, but previous infection with SARS-CoV-2 provides some protection. A study found that neutralizing anti-RBD IgG antibodies were the primary correlate of protection for transplant recipients. Immunosuppressive drugs may affect the generation of virus-specific B and T follicular helper cells. Administration of a third dose of SARS-CoV-2 mRNA vaccine improved the RBD-specific responses in transplant patients who had not previously responded to two doses of the vaccine.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US

Jing Sun et al.

Summary: The study revealed that full vaccination was associated with reduced risk of COVID-19 breakthrough infection, regardless of the immune status of patients. Despite full vaccination, persons with immune dysfunction had substantially higher risk for COVID-19 breakthrough infection than those without such a condition. Continued use of nonpharmaceutical interventions (eg, mask wearing) and alternative vaccine strategies (eg, additional doses or immunogenicity testing) are recommended for persons with immune dysfunction after full vaccination.

JAMA INTERNAL MEDICINE (2022)

Add to Collection

Article Surgery

Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients

Marta Kantauskaite et al.

Summary: Kidney transplant recipients (KTRs) have a weaker immune response to SARS-CoV-2 vaccination compared to controls, with mycophenolate mofetil (MMF) treatment being the strongest predictor for impaired response. Adjusting MMF dose may improve the immune response in KTRs.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Letter Rheumatology

Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series

Caoilfhionn M. Connolly et al.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection

Letter Surgery

Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response

Karsten Midtvedt et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Article Surgery

Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine

Deepali Kumar et al.

Summary: The Omicron variant of the SARS-CoV-2 virus has become the dominant circulating strain globally, and three doses of mRNA COVID-19 vaccine are recommended for transplant recipients. However, there is limited research on the immunogenicity of mRNA vaccines specifically against the Omicron variant. This study analyzed the neutralization effects of Omicron in transplant recipients who received three doses of mRNA-1273 vaccine, and the results showed poor neutralizing responses against the Omicron variant in these patients.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Letter Immunology

Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients

Jonathan Mitchell et al.

TRANSPLANTATION (2022)

Add to Collection

Letter Immunology

Incidence and Severity of COVID-19 Among Vaccinated Solid Organ Transplant Recipients During the Omicron Wave

Jennifer L. Alejo et al.

TRANSPLANTATION (2022)

Add to Collection

Article Immunology

A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response

Andrew H. Karaba et al.

Summary: Humoral responses to COVID-19 vaccines are attenuated in solid organ transplant recipients. Additional vaccine doses can increase neutralizing capacity against multiple variants of concern, but the neutralization effect against the Omicron variant is poor.

TRANSPLANTATION (2022)

Add to Collection

Article Medicine, Research & Experimental

Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients

Eva Schrezenmeier et al.

Summary: Transplant recipients may have impaired immunity after SARS-CoV-2 vaccination due to immunosuppression caused by mycophenolate (MPA). Temporary MPA hold has been shown to greatly improve the outcomes of booster vaccination in these patients.

JCI INSIGHT (2022)

Add to Collection

Review Medicine, General & Internal

Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant A Systematic Review and Meta-Analysis

Kasama Manothummetha et al.

Summary: This systematic review and meta-analysis found that solid organ transplant recipients had low rates of positive antibody response despite receiving multiple doses of mRNA vaccines. Factors associated with poor antibody response included older age, deceased donor status, antimetabolite use, and recent exposure to rituximab or antithymocyte globulin.

JAMA NETWORK OPEN (2022)

Add to Collection

Editorial Material Medicine, General & Internal

A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines

Peter B. Gilbert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure

Catherine J. Reynolds et al.

Summary: This study investigated the immune response of triple BioNTech BNT162b2 mRNA-vaccinated healthcare workers to the B.1.1.529 variant. It was found that individuals vaccinated with three doses showed enhanced immunity against previous variants, but reduced immune response to B.1.1.529. Individuals previously infected with other variants showed enhanced immunity against earlier variants, but reduced immune response to B.1.1.529.

SCIENCE (2022)

Add to Collection

Article Multidisciplinary Sciences

Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings

Victor H. Ferreira et al.

Summary: Transplant recipients who are partially or fully vaccinated after infection with Omicron BA.1 have the strongest immune response, including high levels of neutralizing antibodies and polyfunctional T-cell responses. These patients also show cross-neutralization against BA.2. Immunocompromised individuals are at risk for severe COVID-19, and these findings have implications for understanding the risk of infection, reinfection, and disease severity in this population.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Surgery

Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study

Dafna Yahav et al.

Summary: The immune response to two doses of SARS-CoV-2 mRNA vaccine is limited among kidney transplant recipients. This study aimed to evaluate the humoral and cellular response to a third dose of the BNT162b2 vaccine. The results showed that the third dose improved the immune response among kidney transplant recipients, although 30% of them remained seronegative. Temporary reduction of immunosuppression before vaccination was found to improve the antibody response.

TRANSPLANT INTERNATIONAL (2022)

Add to Collection

Letter Multidisciplinary Sciences

Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response

Karsten Midtvedt et al.

NATURE (2022)

Add to Collection

Article Urology & Nephrology

B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients

Eva Schrezenmeier et al.

Summary: The study found that 36% of kidney transplant recipients showed seroconversion after receiving a third dose of vaccine, highlighting the need for individual humoral monitoring and continued efforts to adapt vaccination protocols for immunosuppressed individuals. The quantitative and qualitative changes in cellular immunity associated with seroconversion emphasize the importance of modified vaccination approaches for this at-risk group.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection

Letter Medicine, General & Internal

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Surgery

Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients

Victoria G. Hall et al.

Summary: Solid organ transplant recipients are at high risk of severe COVID-19. A study on the immunogenicity of mRNA-1273 vaccine in this population showed that a subset of patients developed neutralizing antibodies and CD4+ T cell responses, emphasizing the importance of vaccination in this patient population.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Add to Collection

Letter Surgery

Severe consequences of COVID-19 infection among vaccinated kidney transplant recipients

Noam Tau et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Add to Collection

Letter Medicine, General & Internal

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

William A. Werbel et al.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

Ilies Benotmane et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients

Jan Havlin et al.

Summary: Transplant recipients showed weaker antibody response to mRNA COVID-19 vaccine compared to natural infection, with only a subset of patients demonstrating SARS-CoV-2 specific T-cell response. Further research is needed to identify the optimal vaccine type and schedule for immunocompromised transplant patients.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)

Add to Collection

Letter Urology & Nephrology

Occurrence of severe COVID-19 in vaccinated transplant patients

Sophie Caillard et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Article Multidisciplinary Sciences

Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine

Valerie Oberhardt et al.

Summary: After vaccination, CD8(+) T cells become important effector cells in providing early protection, being effectively mobilized one week after primary vaccination and maintaining stability after booster vaccination. Compared with natural infection, vaccine-induced CD8(+) T cells exhibit similar functional capacities but with a different subset distribution.

NATURE (2021)

Add to Collection

Article Immunology

Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients

Hector Rincon-Arevalo et al.

Summary: Patients with kidney failure are at increased risk for SARS-CoV-2 infection, making effective vaccination critical. However, studies have found significantly impaired antibody responses to the BNT162b2 vaccine in kidney transplant recipients and dialysis patients, leading to insufficient immune responses.

SCIENCE IMMUNOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Sabra Klein et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Article Immunology

SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors

Alina S. Shomuradova et al.

IMMUNITY (2020)

Add to Collection

Article Multidisciplinary Sciences

Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing

Mark Klinger et al.

PLOS ONE (2015)

Add to Collection

Article Mathematical & Computational Biology

Effective communication of standard errors and confidence intervals

Thomas A. Louis et al.

BIOSTATISTICS (2009)

Add to Collection

Article Virology

Severe acute respiratory syndrome coronavirus gene 7 products contribute to virus-induced apoptosis

Scott R. Schaecher et al.

JOURNAL OF VIROLOGY (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.